The DOI matches its Crossref record.
Treatment of female pattern hair loss with oral antiandrogens
Abstract
BACKGROUND: It has not been conclusively established that female pattern hair loss (FPHL) is either due to androgens or responsive to oral antiandrogen therapy. OBJECTIVES: To evaluate the efficacy of oral antiandrogen therapy in the management of women with FPHL using standardized photographic techniques (Canfield Scientific), and to identify clinical and histological parameters predictive of clinical response. METHODS: For this single-centre, before-after, open intervention study, 80 women aged between 12 and 79 years, with FPHL and biopsy-confirmed hair follicle miniaturization [terminal/vellus (T/V) hair ratio < or = 4 : 1] were photographed at baseline and again after receiving a minimum of 12 months of oral antiandrogen therapy. Forty women received spironolactone 200 mg daily and 40 women received cyproterone acetate, either 50 mg daily or 100 mg for 10 days per month if premenopausal. Women using topical minoxidil were excluded. Standardized photographs of the midfrontal and vertex scalp were taken with the head positioned in a stereotactic device. Images were evaluated by a panel of three clinicians experienced in the assessment of FPHL, blinded to patient details and treatment and using a three-point scale. RESULTS: As there was no significant difference in the results or the trend between spironolactone and cyproterone acetate the results were combined. Thirty-five (44%) women had hair regrowth, 35 (44%) had no clear change in hair density before and after treatment, and 10 (12%) experienced continuing hair loss during the treatment period. Ordinal logistic regression analysis to identify predictors of response revealed no influence of patient age, menopause status, serum ferritin, serum hormone levels, clinical stage (Ludwig) or histological parameters such as T/V ratio or fibrosis. The only significant predictor was midscalp clinical grade, with higher-scale values associated with a greater response (P = 0.013). CONCLUSION: Eighty-eight percent of women receiving oral antiandrogens could expect to see no progression of their FPHL or improvement. High midscalp clinical grade was the only predictor of response identified. A placebo-controlled study is required to compare this outcome to the natural history of FPHL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14537 · Cited by 410
Medical treatments for male and female pattern hair loss
Rogers, N. E., & Avram, M. R. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.07.001 · Cited by 309
Androgenetic Alopecia: An Update of Treatment Options
Kelly, Y., Blanco, A., & Tosti, A. (2016) · Drugs · doi:10.1007/s40265-016-0629-5 · Cited by 274
Androgenetic Alopecia: An Evidence-Based Treatment Update
Varothai, S., & Bergfeld, W. F. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0077-5 · Cited by 258
Interventions for female pattern hair loss
van Zuuren, E. J., Fedorowicz, Z., Carter, B., Andriolo, R. B., & Schoones, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007628.pub3 · Cited by 64
Metadata
- Authors
- Sinclair, R., Wewerinke, M., & Jolley, D.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03
- Volume
- 152
- Issue
- 3
- Pages
- 466-473
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W1987854607
- Cited by
- 245
- References
- 0
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of female pattern hair loss with oral antiandrogens. https://app.cochat.ai/papers/10.1111/j.1365-2133.2005.06218.x
- The paper
- Sinclair, R., Wewerinke, M., & Jolley, D. (2005). Treatment of female pattern hair loss with oral antiandrogens. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2005.06218.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.